MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
AVITA Medical DPO Ratio 2011-2026 | RCEL
Annual DPO Ratio AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 532 | 146 | 194 | 715 | 1.4 K | 506 | 240 | 524 | 385 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.4 K | 146 | 516 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
56 | $ 9.25 | 3.01 % | $ 331 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.13 | 6.22 % | $ 1.29 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.57 | 0.26 % | $ 737 M | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.34 | -1.11 % | $ 21.6 M | USA |
 |
IRadimed Corporation
IRMD
|
34.8 | $ 102.27 | 1.29 % | $ 1.3 B | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.44 | 1.9 % | $ 171 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 63.45 | 1.68 % | $ 3.46 B |  Britain |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
LENSAR
LNSR
|
66 | $ 5.65 | 1.62 % | $ 65.1 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 36.82 | 0.71 % | $ 1.14 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
32.2 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 24.9 | 0.81 % | $ 211 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Medtronic PLC
MDT
|
76.2 | $ 87.85 | 1.47 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
54.8 | $ 4.13 | -0.12 % | $ 610 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.66 | -4.56 % | $ 35.9 M | USA |
 |
Aethlon Medical
AEMD
|
61.8 | $ 2.4 | 11.11 % | $ 3.75 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Orthofix Medical
OFIX
|
76.3 | $ 11.86 | 1.19 % | $ 470 M |  Curacao |
 |
InspireMD
NSPR
|
72.3 | $ 1.76 | -0.56 % | $ 113 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.38 | -0.87 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
26.1 | $ 336.12 | 0.58 % | $ 13.1 B | USA |
 |
Myomo
MYO
|
34.8 | $ 0.7 | 0.22 % | $ 29.3 M | USA |
 |
Insulet Corporation
PODD
|
22.5 | $ 220.23 | -2.34 % | $ 15.5 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
46 | $ 2.31 | -3.96 % | $ 136 M | Israel |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.76 | -3.84 % | $ 140 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 16.37 | 2.89 % | $ 384 M | USA |
 |
Quanterix Corporation
QTRX
|
50.7 | $ 3.97 | 3.93 % | $ 169 M | USA |
 |
Outset Medical
OM
|
11.1 | $ 3.53 | - | $ 53.7 K | USA |